Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Precision Medicine in Oncology
®
Neoadjuvant HER2+
Bone Metastases
Brain Cancer
Business Management
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Genitourinary Cancers
Head & Neck Cancers
Hematologic Oncology
Immunotherapy in GU Cancers
Immunotherapy in Lung Cancer
Immunotherapy in Melanoma
Mantle Cell Lymphoma
Melanoma & Skin Cancer
Non-Hodgkin Lymphoma
Oncology Nursing News
Patient Resources
Sarcomas/TGCT
Special Reports in Personalized Cancer Care
Supportive Care
Online CME
Interactive Publications
SELECT A TOPIC
CURRENT VIEW
All Specialties
▲
Education ▲
Education ▼
Register
|
Login
Conference Coverage
Videos
NewsNetwork
OncLive
®
TV
Peer Exchange
Insights
Attend An Event
State of the Science Summit
Regional Seminar Series
PER Conferences
Giants of Cancer Care
ISGIO
Webinars
OncLive Community
SPECIALTY TOPICS
CURRENTLY VIEWING
All Specialties
Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Precision Medicine in Oncology
®
Neoadjuvant HER2+
More >>
OncLive TV: Joyce A. O’Shaughnessy, MD
<< Back to Our Featured Experts
Dr. O'Shaughnessy on Role of Chemotherapy in Future TNBC Treatment
Dr. O'Shaughnessy Discusses New Developments in Molecular Profiling in Breast Cancer
Dr. O'Shaughnessy on Using Phosphoprotein Assays to Personalize Treatment for Breast Cancer
Dr. O'Shaughnessy on Adding Phosphoprotein Testing to Genomic Testing for Breast Cancer
Dr. O'Shaughnessy on Phosphoprotein Assays for Treatment Decision-Making for Breast Cancer
Dr. O'Shaughnessy on Eribulin in Metastatic Breast Cancer
Dr. O'Shaughnessy Describes the School of Breast Oncology
Dr. O'Shaughnessy on the Future of TNBC Treatment
Dr. O'Shaughnessy on the Future of Breast Cancer
Dr. O'Shaughnessy on Breast Cancer Biomarkers
Dr. O'Shaughnessy on Negative TNBC Iniparib Results
Dr. O'Shaughnessy on Avastin as Her Standard of Care
Dr. O'Shaughnessy on Continued Access to Avastin
Oncology Specialists
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Gregory E. Idos, MD
James K. McCloskey II, MD
Charles A. (Trey) Leath III, MD
Charles A. Leath III, MD
David H. Ilson, MD, PhD
Raghava R. Induru, MD
Jeffrey R. Infante, MD
Brant Inman, MD
George N. Ioannou, MD
Syma Iqbal, MD
Luisa Iruela-Arispe, PhD
Melinda L. Irwin, PhD
Claudine Isaacs, MD
Tim Iveson, MD, FACP
Toshiaki Iwase, MD
Hiroji Iwata, MD, PhD
Puneeth Iyengar, MD
Gopa Iyer, MD
Renuka Iyer, MD
OncLive News Network On Location: ASH 2019 Day 3
Trending Now
Chemo-Free Regimen Matches Neoadjuvant Chemo in HR+/HER2- Breast Cancer
Residual Cancer Burden Predicts Patient Outcomes Across Breast Cancer Subtypes
Key Takeaway 4: Second-Line Regorafenib After TKI in HCC
Estrogen Decreases Breast Cancer Incidence in Postmenopausal Women, Estrogen Plus Progestin Has Opposite Effect
Publications
Covering Every Angle of Oncology Practice. Click a cover below, to view more.
x
Subscribe